<?xml version="1.0" encoding="UTF-8"?>
<collection>
<dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:invenio="http://invenio-software.org/elements/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:identifier>doi:10.3390/diagnostics13172778</dc:identifier><dc:language>eng</dc:language><dc:creator>Fernández-Gomez, Beatriz</dc:creator><dc:creator>Menao-Guillén, Sebastian</dc:creator><dc:creator>Fernandez Gonzalez, Ayla</dc:creator><dc:creator>Arruebo Muñio, Maria</dc:creator><dc:creator>Ramos Alvarez, Monica</dc:creator><dc:creator>Inda Landaluce, Mercedes</dc:creator><dc:creator>Castillo Arce, Maria Angeles</dc:creator><dc:creator>Torralba-Cabeza, Miguel Ángel</dc:creator><dc:title>Utility of the serum protein electrophoresis in the opportunistic screening for the deficiency of Alpha-1 Antitrypsin</dc:title><dc:identifier>ART-2023-135079</dc:identifier><dc:description>Background: A deficiency in alpha-1 antitrypsin (AAT1) is a rare disorder that represents a significant health threat and early diagnostic priority issue. We investigated the usefulness of the serum protein electrophoresis (SPE) as an opportunistic screening tool for AAT1 deficiency. Methods: For 6 months, all SPE carried out for any reasons were evaluated in our center. In those with less than 3% of alpha-1 globulins, AAT1 concentrations were studied. The SERPINA1 gene was subsequently sequenced in those patients displaying concentrations below 100 mg/dL. Results: Out of the total, 14 patients (0.3%) were identified with low AAT1 concentrations, with 11 of them agreeing to enter the study. Of those, mutations in the SERPINA1 gene were discovered in 10 patients (91%). Heterozygous mutations were detected in seven patients; three had the c.1096G&amp;gt;A mutation (p.Glu366Lys; Pi*Z), two had the c.863A&amp;gt;T mutation (p.Glu288Val; Pi*S), one had the c.221_223delTCT mutation (p.Phe76del; Pi*Malton), and the last one had the c.1066G&amp;gt;A (p.Ala356Thr) mutation, which was not previously described. Finally, one patient had the c.863A&amp;gt;T mutation in homozygosis, whereas two double heterozygous patients c.863A&amp;gt;T/c.1096G&amp;gt;A were detected. Conclusions: An altered result in the concentration of AAT1 anticipates a mutation in the SERPINA1 gene in a manner close to 91%. The relationship between a decrease in the alpha-1 globulin band of the SPE and an alteration in the AAT1 concentration is direct in basal states of health. The SPE is presented as a highly sensitive test for opportunistic screening of AAT1 deficiency.</dc:description><dc:date>2023</dc:date><dc:source>http://zaguan.unizar.es/record/127906</dc:source><dc:doi>10.3390/diagnostics13172778</dc:doi><dc:identifier>http://zaguan.unizar.es/record/127906</dc:identifier><dc:identifier>oai:zaguan.unizar.es:127906</dc:identifier><dc:identifier.citation>Diagnostics 13, 17 (2023), 2778 [9 pp]</dc:identifier.citation><dc:rights>by</dc:rights><dc:rights>http://creativecommons.org/licenses/by/3.0/es/</dc:rights><dc:rights>info:eu-repo/semantics/openAccess</dc:rights></dc:dc>

</collection>